Exbio — Research products — Antibodies — CD and related antigens — Anti-DLL4 Purified

Anti-DLL4 Purified

Anti-DLL4 Purified
Regulatory status
RUO
Antigen
DLL4
Clone
MHD4-46
Format
Purified
Reactivity
Human
Application
FC (QC tested)
Variant
0.1 mg
11-717-C100
In stock
100.00 USD
0.025 mg
11-717-C025
Out of stock
50.00 USD
Variant
0.1 mg
11-261-C100
In stock
100.00 USD
0.1 mg
11-261-C100
In stock
50.00 USD
Contact us
Product details
Images
References
Isotype
Mouse IgG1 kappa
Specificity
The mouse monoclonal antibody MHD4-46 recognizes the extracellular domain of DLL4 (Delta-like ligand 4), a type I transmembrane protein which plays an important role in vascular development.
Application
FC (QC tested)
Reactivity
Human
Immunogen
recombinant soluble human DLL4
Other names
Delta like ligand 4, AOS6, canonical Notch ligand 4
Concentration
1 mg/ml
Preparation
Purified by protein-A affinity chromatography
Formulation
Phosphate buffered saline (PBS) solution with 15 mM sodium azide
Storage and handling
Store at 2-8°C. Do not freeze. Do not use after expiration date stamped on vial label.
Exbio licence note
Unless indicated otherwise, all products are For Research Use Only and not for diagnostic use. In vivo diagnostic or therapeutic applications are strictly forbidden. Products shall not be used for resale or transfer to third parties either as a stand-alone product or as a manufacture component of another product without written consent of EXBIO Praha, a.s. EXBIO Praha, a.s. will not be held responsible for patent infringement or any other violations of intellectual property rights that may occur with the use of the products. Orders for all products are accepted subject to the Term and Conditions available at www.exbio.cz. EXBIO, EXBIO Logo, and all other trademarks are property of EXBIO Praha, a.s. © 2019 EXBIO Praha, a.s. All rights reserved.
11-717 FC
Flow cytometry analysis (sSurface staining) of DLL4 in HD4 cells transfected with DLL4, using mouse monoclonal anti-DLL4 (MAD4-46) purified, GAM/APC.

Product specific references:

Yamanda S, Ebihara S, Asada M, Okazaki T, Niu K, Ebihara T, Koyanagi A, Yamaguchi N, Yagita H, Arai H: Role of ephrinB2 in nonproductive angiogenesis induced by Delta-like 4 blockade. Blood. 2009 Apr 9;113(15):3631-9
PubMed
Oishi H, Sunamura M, Egawa S, Motoi F, Unno M, Furukawa T, Habib NA, Yagita H: Blockade of delta-like ligand 4 signaling inhibits both growth and angiogenesis of pancreatic cancer. Pancreas. 2010 Aug;39(6):897-903
PubMed
Sekine C, Koyanagi A, Koyama N, Hozumi K, Chiba S, Yagita H: Differential regulation of osteoclastogenesis by Notch2/Delta-like 1 and Notch1/Jagged1 axes. Arthritis Res Ther. 2012 Mar 5;14(2):R45.
PubMed
Variant
0.1 mg
11-717-C100
In stock
100.00 USD
0.025 mg
11-717-C025
Out of stock
50.00 USD
Variant
0.1 mg
11-261-C100
In stock
100.00 USD
0.1 mg
11-261-C100
In stock
50.00 USD
Contact us
Datasheet download
SDS download
Bulk requests
Technical support for this product